SCHEMBL571247

SCHEMBL571247

CCC1=C(C)C(=O)c2cc(OC)c(OC)cc2C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MALT1 Q9UDY8 1/20 0.41
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
PDE3B Q13370 2/20 0.39
PDE3A Q14432 2/20 0.39
USP8 P40818 1/20 0.38
USP7 Q93009 1/20 0.38
CDK4 P11802 1/20 0.37
CCND1 P24385 1/20 0.37
GSK3B P49841 1/20 0.37
CDC25A P30304 1/20 0.37
CDC25B P30305 1/20 0.37
KDM4E B2RXH2 3/20 0.36
LCK P06239 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KMT2A Q03164 2/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL571947 0.86 MAPT (0.42) MALT1CA1CA2CA7CA9
SCHEMBL571095 0.83 MAPT (0.51) MALT1PDE3BPDE3AALDH1A1CYP3A4
SCHEMBL571575 0.82 MAPT (0.58) PDE3AALDH1A1CYP3A4MAOA
SCHEMBL571989 0.80 MAPT (0.60) PDE3AALDH1A1CYP3A4MAOA
SCHEMBL571500 0.80 MAPT (0.60) PDE3AALDH1A1CYP3A4MAOA
SCHEMBL571008 0.80 MAPT (0.60) PDE3AALDH1A1CYP3A4MAOA
SCHEMBL571593 0.80 MAPT (0.60) PDE3AALDH1A1CYP3A4MAOA
SCHEMBL571069 0.80 MAPT (0.60) PDE3AALDH1A1CYP3A4MAOA
SCHEMBL571497 0.80 NQO1 (0.43) PDE3ACDC25ACDC25BKDM4EL3MBTL1
SCHEMBL571419 0.78 IDO1 (0.59) MALT1CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015183985-A2 THERAPEUTIC COMPOSITIONS INCLUDING NAPHTHOQUINONES AND USES THEREOF STEALTH PEPTIDES INTERNATIONAL, INC. (MC) 2015-12-03 WO disclosed
EP-2600857-A2 TREATMENT OF MITOCHONDRIAL DISEASES WITH NAPHTHOQUINONES Edison Pharmaceuticals, Inc. (US) 2013-06-12 EP disclosed
WO-2012019029-A2 TREATMENT OF MITOCHONDRIAL DISEASES WITH NAPHTHOQUINONES EDISON PHARMACEUTICALS, INC. (US) 2012-02-09 WO disclosed